earnings
confidence high
sentiment positive
materiality 0.75
Organogenesis Q3 revenue up 6% to $115.2M, net income $12.3M vs $3.2M; updates FY guidance
Organogenesis Holdings Inc.
2024-Q3 EPS reported
-$0.05
revenue$355,387,000
- Net revenue $115.2M (+6% YoY); Advanced Wound Care $108.0M (+7%).
- GAAP net income $12.3M ($0.09 diluted EPS) vs $3.2M ($0.02) YoY.
- Adjusted EBITDA $13.4M, down from $16.0M; Non-GAAP operating income $7.1M vs $11.0M.
- Cash $94.9M, net debt $62.1M; FY guidance: rev $455-480M, adj net income $6.7-18.4M.
- CEO cites brand equity and work with policymakers on access solution.